Delivery Order SPE2DB25D3018-SPE2DB25FUYNQ
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $1,451.96 delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was placed with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Protopam Chloride is a cholinesterase reactivator used in medical countermeasures...
- The Defense Logistics Agency awarded a $5,960.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of July 24, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $1,341.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of July 25, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement needs, particularly...
- The Defense Logistics Agency awarded a $2,263.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of August 1, 2025. This competitive award includes no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Protopam Chloride 1 GM vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,540.93 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials with a ceiling value of $8,760.11 under a firm fixed-price contract. This award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a child delivery order under the contractor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency awarded a $1,451.96 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Protopam Chloride 1 GM vials, with completion scheduled for June 10, 2025. This firm fixed-price contract represents a non-set-aside award made through open competition. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,446.99 delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,070.97 to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of September 11, 2025. This contract utilizes firm fixed pricing and was awarded on a non-set-aside, competitive basis. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Protopam Chloride 1 GM vials with a ceiling value of $5,777.60. This firm fixed-price contract, which has an ultimate completion date of August 7, 2025, represents a routine pharmaceutical procurement supporting the federal medical supply chain. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's established relationship...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYNQDelivery Order
The Defense Logistics Agency awarded a $2,939.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of September 18, 2025. This non-set-aside contract was competitively awarded on September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Protopam Chloride is a critical antidote used in emergency medical situations, particularly for organophosphate poisoning treatment in military and civilian healthcare settings. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant standing as a critical federal medical procurement vendor with demonstrated capability to fulfill federal requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/17/25 |